August 16 – Jointown Pharmaceutical Group (600998) posted a 7.49-percent year-on-year increase in interim net profits to 126 million yuan, reports yicai.com, citing a company filing.

Sales revenues during that period rose 17.01 percent year-on-year to 12.03 billion yuan.

The firm sped up mergers and acquisitions during that period as it formed a subsidiary in Hubei and acquired an 81.49-percent stake in Hubei Xianglian Pharmaceutical Limited, the source noted.